Status:
RECRUITING
Reduced Port Laparoscopic Gastrectomy for Gastric Cancer
Lead Sponsor:
Nanchong Central Hospital
Conditions:
Laparoscopic
Gastrectomy
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Reduced port laparoscopic gastrectomy has been adopted in clinical. The safety and outcome of reduced port laparoscopic gastrectomy has not been systematically evaluated. The investigators sought to c...
Detailed Description
Reduced port laparoscopic gastrectomy has been adopted in clinical. The safety and outcome of reduced port laparoscopic gastrectomy has not been systematically evaluated. The investigators designed a ...
Eligibility Criteria
Inclusion
- Histologically confirmed adenocarcinoma of the stomach, T1-T4 stages.
- Eastern Cooperative Oncology Group performance status of 0 or 1.
- Adequate organ function.
Exclusion
- Patients had distant metastasis.
- oesophageal invasion of more than 3 cm.
- Borrmann type 4 or large (more than 8 cm) type 3 carcinoma.
- Previous chemotherapy or radiation therapy for any other malignancies.
Key Trial Info
Start Date :
March 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04295473
Start Date
March 2 2020
End Date
March 1 2027
Last Update
May 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yunhong Tian
Nanchong, Sichuan, China, 637000